You searched for "Clinics"

2532 results found

A game changer in meibomian gland treatment

Introducing the new Meibomian Gland Dredger by Gaush Meditech Ltd. Meibomian gland dredging is important in the treatment of dry eye and has a great influence on treatment outcomes. Many types of dye eye treatment combined with meibomian gland dredging...

Birmingham Optical Achieves UKAS ISO 9001 Certification

Birmingham Optical, a leading UK provider of optical equipment and services, has been awarded the prestigious UKAS ISO 9001 certification, a globally recognised standard for quality management systems (QMS). This milestone reflects the company’s dedication to excellence, consistency, and customer...

UKISCRS Annual Congress Image Contest

Are you an ophthalmic trainee in the UK or Ireland? Have you always wanted to attend the UKISCRS Annual Congress? Scope Eyecare are delighted to announce the UKISCRS Annual Congress Image Contest. Enter this contest and you could attend the...

Navigating an Ophthalmology Lab-Based Research Elective: Reflections and Insights from Johns Hopkins Wilmer Eye Institute

Medical school electives offer valuable opportunities to gain exposure to different healthcare systems and bridge specific gaps in training. While clinical electives are often the primary choice for medical students, research-focused electives also present unique benefits, particularly for those interested...

Surgitrac Instruments to Exhibit at UKISCRS Cornea & Cataract Day

Surgitrac Instruments is pleased to announce its participation in the United Kingdom & Ireland Society of Cataract and Refractive Surgeons (UKISCRS) Cornea & Cataract Day 2026, taking place on 16 March in Edinburgh. The event brings together leading ophthalmic professionals...

Clinical outcomes following intraluminal stent removal from the PAUL glaucoma implant

This single German centre retrospective cohort study included 70 eyes from 68 patients. Qualified and complete success rates (95% CI) were 92.9% and 55.7% after 1 year and 88.6% (81.4–95.7%) and 50% (37.1–62.9%) at the last follow-up time point for...

Visual acuity improvement in amblyopic eyes following fellow eye vision loss

The authors present a systematic review with the aim of reporting how frequently and to what extent amblyopia recovers following the loss of vision in the fellow eye and identify any potential clinical predictors. Studies including adults with amblyopia and...

The results of the last survey Feb24

Thank you to all those who participated in this edition’s survey and for those of you who attended my recent Medico-legal Seminar at the Royal College of Ophthalmologists. It was a fascinating and educational day, made a success by the...

A paediatric case of central retinal artery occlusion following antibiotics and decompression surgery for orbital cellulitis

Orbital cellulitis is an ophthalmic emergency that warrants urgent management in the hospital setting [1]. This occurs more frequently in the paediatric population where it is often secondary to sinus infections. Delay in treatment could result in severe complications including...

Record rise in competition ratios for ophthalmology: What does this mean for the future of the ophthalmology training programme?

In this article, Adina Smith discusses factors likely to contribute to the record rise in competition ratios and the impact this may have on the future of OST. Ophthalmology specialty training (OST) is the fifth most competitive training programme in...

Typical or surprisingly uncharacteristic presentations of neuro-ophthalmic emergencies

Irrespective of geographical location or patient cohort, emergency departments are high risk locations capable of inspiring extreme anxiety and dread in patients and doctors alike. The stress multiplies when a walk-in or referred case is suspected of underlying neurological pathology....

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.